| Biomarker ID | 698 |
| PMID | 21804560 |
| Year | 2011 |
| Biomarker | PCAT-1 |
| Biomarker Basis | Expression Based |
| Biomolecule | ncRNA |
| Source | Tissue |
| Subjects | Humans |
| Regulation | Upregulated in a subset of metastatic and high-grade localized (Gleason score ≥7) cancers |
| Odds Ratio/Hazard Ratio/Relative Risk | NA |
| Effect on Pathways | NA |
| Experiment | High grade tumor vs. low grade tumor/non-tumor |
| Type of Biomarker | Prognostic |
| Cohort | 102 prostate tissues and cell lines: 20 benign adjacent prostates (benign), 47 localized prostate cancers (PCA), 14 metastatic tumors and 21 prostate cell lines were selected for analysis. |
| Senstivity | NA |
| Specificity | NA |
| AUC | NA |
| Accuracy | NA |
| Level Of Significance | NA |
| Method Used | RNA-seq |
| Clinical | No |
| Remarks | NA |
| Clinical Trial Number | NA |
| Degree Of Validity | Validated on two independent patient cohorts |
| Technical Name | PCAT1 |